Latest updates for Adap

Fresh curated links around ADAP are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million
  • Florida’s AIDS drug program’s future remains unresolved
  • Spotlight On: Humira® (adalimumab) / Amjevitaâ„¢ (adalimumab-atto) / Cyltezo® (adalimumab-adbm) / Hyrimozâ„¢ (adalimum

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /4 days ago

Harvest Investment Services Dumps 356,000 Adaptive Biotechnologies (ADPT) Shares Worth $5.7 Million

Adaptive Biotechnologies develops immune-driven diagnostics and research tools for the life sciences and healthcare sectors.

Read source
orlandoweekly.com /2 weeks ago

Florida’s AIDS drug program’s future remains unresolved

Read source
jdsupra.com /1 month ago

Spotlight On: Humira® (adalimumab) / Amjevita™ (adalimumab-atto) / Cyltezo® (adalimumab-adbm) / Hyrimoz™ (adalimum...

Adalimumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the...

Read source
jdsupra.com /2 weeks ago

Spotlight On: Humira® (adalimumab) / Amjevita™ (adalimumab-atto) / Cyltezo® (adalimumab-adbm) / Hyrimoz™ (adalimum...

Adalimumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Adap

fool.com

Recent coverage from public sources
Public source

jdsupra.com

Recent coverage from public sources
Public source

jdsupra.com

Recent coverage from public sources
Public source

orlandoweekly.com

Recent coverage from public sources
Public source